Mirati Therapeutics, Inc. (MRTX) Analyst Forecast

NASDAQ Currency in USD Disclaimer

$58.70

north_east NA Past Year
Day's range
$58.54
Day's range
$58.99

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
12/13/2022 Piper Sandler Swapnil Malekar $68.00 $41.97   62.02%
12/07/2022 BMO Capital Evan Seigerman $59.00 $49.59   18.98%
12/07/2022 Piper Sandler Swapnil Malekar $84.00 $49.59   69.39%
01/31/2022 Bank of America Securities Jason Gerberry $141.00 $123.02   14.62%
09/20/2021 H.C. Wainwright Edward White $247.00 $167.09   47.82%
09/19/2021 Jefferies Maury Raycroft $193.00 $177.45   8.76%

Mirati Therapeutics, Inc. FAQ's

Mirati Therapeutics, Inc. has been rated by research analysts at Morgan Stanley, Leerink Partners, Piper Sandler, Citigroup, Oppenheimer, J.P. Morgan in the past 90 days.